BusinessCannabis Science Expands 5-Year Agreement With Dana-Farber Cancer Institute to Develop Cannabinoid-Based Medications and Associated Delivery Technologies for the Treatment of CancersBy Nasdaq OMXFeb 2, 2018, 8:07 PM UTC
